Enhanced recovery after surgery in transurethral surgery for benign prostatic hyperplasia

Enhanced recovery after surgery(ERAS)measures have not been systematically applied in transurethral surgery for benign prostatic hyperplasia(BPH).This study was performed on patients with BPH who required surgical intervention.From July 2019 to June 2020,the ERAS program was applied to 248 patients,and the conventional program was applied to 238 patients.After 1 year of follow-up,the differences between the ERAS group and the conventional group were evaluated.The ERAS group had a shorter time of urinary catheterization compared with the conventional group(mean±standard deviation[s.d.]:1.0±0.4 days vs 2.7±0.8 days,P<0.01),and the pain(mean±s.d.)was significantly reduced through postoperative hospitalization days(PODs)0-2(POD 0:1.7±0.8 vs 2.4±1.0,P<0.01;POD 1:1.6±0.9 vs 3.5±1.3,P<0.01;POD 2:1.2±0.7 vs 3.0±1.3,P<0.01).No statistically significant difference was found in the rate of postoperative complications,such as postoperative bleeding(P=0.79),urinary retention(P=0.40),fever(P=0.55),and readmission(P=0.71).The hospitalization cost of the ERAS group was similar to that of the conventional group(mean±s.d.:16927.8±5808.1 Chinese Yuan[CNY]vs 17044.1±5830.7 CNY,P=0.85).The International Prostate Symptom Scores(IPSS)and quality of life(QoL)scores in the two groups were also similar when compared at 1 month,3 months,6 months,and 12 months after discharge.The ERAS program we conducted was safe,repeatable,and efficient.In conclusion,patients undergoing the ERAS program experienced less postoperative stress than those undergoing the conventional program.

Retrospective analysis of the changes in the surgical treatment of benign prostatic hyperplasia during an 11-year period: a single-center experience

The present study aimed to determine whether the number of patients with symptomatic benign prostatic hyperplasia(BPH)who preferred surgery decreased during the past 11 years at our center(West China Hospital,Chengdu,China),and whether this change affected the timing of surgery and the physical condition of surgical patients.This retrospective study included 57557 patients with BPH treated from January 2008 to December 2018.Of these,5427 patients were treated surgically.Surgical patients were divided into two groups based on the time of treatment(groups 8-13 and groups 13-18).The collected data comprised the percentage of all patients with BPH who underwent surgery,baseline characteristics of surgical patients,rehabilitation time,adverse events,and hospitalization costs.The surgery rates in groups 8-13 and groups 13-18 were 10.5%and 8.5%(P<0.001),respectively.The two groups did not clinically differ regarding patient age and prostate volume.The rates of acute urinary retention and renal failure decreased from 15.0%to 10.6%(P<0.001)and from 5.2%to 3.1%(P<0.001),respectively.In groups 8-13 and groups 13-18,the mean catheterization times were 4.0±1.7 days and 3_3±1.6 days(P<0.001),respectively,and the mean postoperative hospitalization times were 5.1±2.4 days and 4.2±1.8 days(P<0.001),respectively.The incidences of unplanned second surgery and death reduced during the study period.The surgery rate decreased over time,which suggests that medication was chosen over surgery.However,the percentage of late complications of BPH also decreased over time,which indicates that the timing of surgery was not delayed.